Description ofthe ICRP Model
The International Commission on Radiological Protection (ICRP) model is the minimal system needed to synthesize a wide variety of data from diverse studies related to the biokinetics of Pb in humans ( Figure 1 ). These include studies of healthy adult humans receiving Pb tracers by injection, ingestion, or inhalation; postmortem measurements of Pb in environmentally exposed men, women, and children; Pb balance studies conducted in humans; and bioassay and autopsy measurements on occupationally exposed subjects. Data on the behavior of Pb in human subjects were supplemented with findings from Pb studies on laboratory animals at different stages of life and with experimental, occupational, environmental, and medical data on the biokinetics of elements with physicochemical properties similar to those of Pb. Finally, modeling of the long-term retention of skeletal deposits of Pb was based on age-dependent data on the rate of bone restructuring, an approach that is supported by human and animal data on many bone-seeking radionuclides (1) .
The ICRP model describes the age-and time-dependent distribution and excretion of Pb injected directly into blood or absorbed from the gastrointestinal tract and/or lung. The schematic diagram of the compartments used in the systemic model and the directions of Pb movement among compartments is shown in Figure 1 . The transfer rates between compartments and the age-dependent physiologic parameters are provided in Leggett (2) . The transport of Pb between compartments follows firstorder kinetics, provided the concentration in the erythrocytes stays below a nonlinear threshold concentration. A nonlinear threshold concentration of 60 pg Pb/g red blood cells (RBC), corresponding to about 25 pg Pb/dl whole blood, has been suggested as a default value (2, 3) , but the threshold level may vary substantially from one person to another and may also depend on the duration of exposure.
Advantgs ofthe ICRP Model
The ICRP model has several distinct differences, advantages, and disadvantages compared with other biokinetic models for Pb ( Table 1) . The advantages and disadvantages may vary in importance depending on the questions asked of the model and the knowledge and experience of the user. A Table 2 ). The default values were used for all Pb absorption, distribution, and other biokinetic parameters in both models. The mother's blood was set to 2.5 pg/dl for both models and the biokinetics of Pb was simulated from birth to 7 years of age. The ICRP model-predicted blood lead (PbB) level at each age is approximately twice the IEUBK model-predicted PbB value when IEUBK Pb uptake is used to define the Pb input to the ICRP model ( Figure 2 and Table 3 ). The default bioavailablity of Pb in water and diet is 50 and 30% for soil and dust in the IEUBK model. The IEUBK model-predicted absorption of the default Pb uptake is between 32 and 35% ( Table 2 ). The default bioavailablity of all gastrointestinal Pb is 45% from birth to 1 year of age and 30% to 5 years of age in the ICRP model. The daily uptake of Pb from the gastrointestinal and respiratory tracts was very similar, except for the period from 6 to 12 months of age ( Figure 3) . Thus, the difference in predicted PbB values is due mainly to differences in the systemic biokinetics (Table 2) .
Simulated Occupational Lead Exposur
The kinetics of Pb in the human skeleton is under investigation in several laboratories using noninvasive X-ray fluorescence (XRF) techniques. In particular, long-term XRF studies on retired Pb workers has provided information on the turnover rate of Pb in bone (7) (8) (9) . In these studies, the observed turnover rate of bone Pb has varied with the length of the follow-up period and the bone selected for measurement. Based on measurements of Pb in finger bone, a mean half-time of 6.7 years was estimated for subjects followed for 5 years after retirement from Pb work, and a mean half-time of 8.2 years was estimated for subjects followed from year 7 to year 13 after retirement (7). In retired workers followed for over 18 years after the end of exposure, the asymptotic mean half-time of Pb in finger bone was 16 years (8) . In active and retired Pb workers followed for many years, the estimated mean half-times of Pb in the tibia (largely cortical bone) and calcaneus (a mixture of trabecular and cortical bone) were 27 years and 16 years, respectively (9). Immediately after subjects were removed from Pb work, PbB levels declined, with a half-time of 30 to 40 days (7, 8) . Descriptions of the long-term decline of -) and IEUBK (------) in the respiratory default Pb intake nvels are provided PbB after retirement depended on the number of exponential terms used and the length of the follow-up period, but eventually the decline in PbB roughly paralleled that in the skeleton (7, 8) .
Only As indicated in the preceding example, retired Pb workers usually show a rapid rate of decline of PbB soon after removal from exposure, but the rate of decline slows over a period of months and eventually parallels that of skeletal Pb (7, (10) (11) (12) . In these subjects, PbB levels generally have remained substantially higher than the average background levels in a matched population for at least a few years, suggesting that bone Pb represents the dominant source of PbB in the retired workers during this period. As in the preceding example, only broad comparisons between these data and model predictions can be made because of inadequate information on the time course and level of exposure of the subjects before, during, and after occupational exposure, and the proper nonlinear threshold (if any) to apply to these exposures. However, for presumably realistic occupational exposure scenarios, model predictions are generally consistent with the conclusion that bone Pb represents the most important source of PbB for at least a few years (Figures 4, 5) and sometimes for several years after retirement.
Simulated Controlied Lead Exposure
Griffin and co-workers (13) determined changes with time in PbB levels in several healthy adult male volunteers who were exposed to elevated levels of airborne Pb for 23 hr/day for about 18 weeks. The average concentration of Pb in air in the exposure chamber varied only slightly with time and averaged 10.9 pg/m3 over the entire exposure period. The mean PbB levels increased to about 37 pg/dl during the exposure compared with a mean of 20.4 pg/dl prior to exposure. PbB levels returned to nearly normal levels about 2 months after the men left the exposure chamber.
To simulate this controlled exposure, input to blood (assumed to represent primarily Pb absorbed from the gastrointestinal tract) was arbitrarily set at a constant, chronic level such that PbB gradually increased over several years (2000 days) to the pre-exposure mean PbB value of 20.4 pg/dl. When this background PbB value was attained, 58 pg/day was assigned to the lungs over the next 125 days, based on a concentration in air of 10.9 pg/m3, an air intake rate of 15 m3/day, an intake time of 23 hr/day, and a lung deposition fraction of 0.37 (2) . Model predictions are compared with observations in Figure 6 .
Simulated Chelation Therapy
Metal-chelating drugs have been used for many years for diagnosis of metal toxicity and to enhance metal diuresis. (14) (15) (16) , little is known regarding the tissue and cellular source of the Pb excreted during chelation in children or in adults (17) (18) (19) (20) .
Chelation is most simply modeled by increasing the deposition fraction of Pb in urine (default 0.015) and uniformly decreasing the total transfer rate from plasma to all other tissues, keeping the total transfer rate from plasma to all destinations at 2000/day. This approach is illustrated and validated by a case report of a Pb-poisoned child. The child lived in an environment of uncharacterized Pb contamination to 421 days of age. He then moved to a home containing Pb paint in a deteriorated condition. His blood Pb reached 40 pg/day at about 1 150 days of age and peaked at 57 pg/dl on day 1228. He was treated with EDTA and BAL for 5 days as an inpatient and then released.
To simulate this exposure, daily Pb intake was adjusted to give PbB levels approximating 40 pg/dl, with a higher intake for 2 months just before the chelation (Figure 7 ). Chelation efficiency, defined in the model as the fraction of the total outflow of Pb from plasma that is assigned to the urinary bladder contents, was empirically set to 0.85 to provide the best fit to the PbB measurements during the chelation period. Table 4 (21) (22) (23) (24) .
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